CBD Eliminated Withdrawal Symptoms in a 19-Year-Old Heavy Cannabis User: A Case Report

A 19-year-old woman with cannabis withdrawal syndrome was treated with CBD for 10 days and showed no significant withdrawal, anxiety, or dissociative symptoms throughout the treatment period.

Crippa, J A S et al.·Journal of clinical pharmacy and therapeutics·2013·Preliminary EvidenceCase Report
RTHC-00669Case ReportPreliminary Evidence2013RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

A 19-year-old heavy cannabis user experiencing withdrawal syndrome (increased anxiety, insomnia, loss of appetite, irritability, restlessness) was treated with cannabidiol (CBD) for 10 days. Daily symptom assessments showed the absence of significant withdrawal symptoms, anxiety symptoms, and dissociative symptoms throughout the treatment.

The rationale for CBD was that cannabis withdrawal results from desensitization of CB1 receptors by THC. CBD interacts with the endocannabinoid system differently from THC and does not produce psychoactive effects, making it a logical candidate for managing the transition off cannabis.

Key Numbers

1 patient, 19 years old, female. CBD treatment for 10 days. Absence of significant withdrawal, anxiety, and dissociative symptoms throughout.

How They Did This

Single case report of a 19-year-old woman with cannabis withdrawal syndrome. CBD administered for 10 days with daily symptom assessments for withdrawal, anxiety, and dissociative symptoms.

Why This Research Matters

Cannabis withdrawal can be severe enough to prevent successful quitting. There are no approved medications for cannabis withdrawal. This case report suggests CBD, a non-psychoactive component of cannabis itself, could manage withdrawal symptoms, providing a basis for larger clinical trials.

The Bigger Picture

Using a non-psychoactive component of cannabis to treat cannabis withdrawal is an elegant therapeutic concept. If confirmed in larger studies, CBD could become the first evidence-based pharmacotherapy specifically for cannabis withdrawal syndrome.

What This Study Doesn't Tell Us

This is a single case report with no control condition. Withdrawal symptoms may have resolved naturally. No dose information was provided in the abstract. The case cannot establish whether CBD directly prevented withdrawal or whether other factors contributed. Case reports are the lowest level of clinical evidence.

Questions This Raises

  • ?What CBD dose is optimal for cannabis withdrawal?
  • ?Would these results replicate in a controlled trial?
  • ?How does CBD compare to other medications tested for cannabis withdrawal?
  • ?Is 10 days sufficient, or would longer treatment be needed?

Trust & Context

Key Stat:
No significant withdrawal symptoms during 10 days of CBD treatment
Evidence Grade:
Single case report; the lowest level of clinical evidence but provides a hypothesis for testing.
Study Age:
Published in 2013. Subsequent studies have begun testing CBD for cannabis use disorder in controlled settings.
Original Title:
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.
Published In:
Journal of clinical pharmacy and therapeutics, 38(2), 162-4 (2013)
Database ID:
RTHC-00669

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can CBD help with cannabis withdrawal?

This case report showed promising results in one patient, but a single case cannot prove effectiveness. However, the biological rationale is sound: CBD interacts with the endocannabinoid system without producing the psychoactive effects of THC. Larger controlled studies are needed to confirm these preliminary findings.

Why would a cannabis compound help with cannabis withdrawal?

CBD and THC are very different molecules. THC causes the high and, with chronic use, leads to receptor desensitization that produces withdrawal when stopped. CBD does not cause a high but may help stabilize the endocannabinoid system during the transition off THC, reducing withdrawal severity.

Read More on RethinkTHC

Cite This Study

RTHC-00669·https://rethinkthc.com/research/RTHC-00669

APA

Crippa, J A S; Hallak, J E C; Machado-de-Sousa, J P; Queiroz, R H C; Bergamaschi, M; Chagas, M H N; Zuardi, A W. (2013). Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.. Journal of clinical pharmacy and therapeutics, 38(2), 162-4. https://doi.org/10.1111/jcpt.12018

MLA

Crippa, J A S, et al. "Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report.." Journal of clinical pharmacy and therapeutics, 2013. https://doi.org/10.1111/jcpt.12018

RethinkTHC

RethinkTHC Research Database. "Cannabidiol for the treatment of cannabis withdrawal syndrom..." RTHC-00669. Retrieved from https://rethinkthc.com/research/crippa-2013-cannabidiol-for-the-treatment

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.